Jubilant DraxImage is dedicated to providing radiopharmaceuticals for the diagnosis and treatment of a variety of diseases. We invite you to learn more about these areas and how our products are used by healthcare professionals to care for their patients.
Bone cancer is relatively rare, accounting for 0.2% of all cancers.1 It can originate in the bone tissue as primary bone cancer, which can be either benign or malignant. More frequently, however, cancer from other parts of the body can metastasize and spread to the bones.2
The most common types of bone cancer are:2
Physicians may perform nuclear imaging tests that provide a view of the entire skeleton to diagnose and monitor bone cancer. These tests can also help physicians detect cancer that has spread from other sites in the body.
Jubilant DraxImage is committed to ensuring continuous availability of radiopharmaceuticals to help healthcare professionals realize the full value of bone imaging to guide patient care.